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This articlepresents an extensionof thecohort-component model of populationprojection
(CCMPP) ﬁrst formulated by Heuveline (2003) that is capable of modeling a population
affected by HIV. Heuveline proposes a maximum likelihood approach to estimate the
age proﬁle of HIV incidence that produced the HIV epidemics in East Africa during the
1990s. WeextendthisworkbydevelopingtheLesliematrixrepresentationoftheCCMPP,
which greatly facilitates the implementation of the model for parameter estimation and
projection. The Leslie matrix also contains information about the stable tendencies of
the corresponding population, such as the stable age distribution and time to stability.
Another contribution of this work is that we update the sources of data used to estimate the
parameters, and use these data to estimate a modiﬁed version of the CCMPP that includes
(estimated) parameters governing the survival experience of the infected population. A
further application of the model to a small population with high HIV prevalence in rural
South Africa is presented as an additional demonstration. This work lays the foundation
for development of more robust and ﬂexible Bayesian estimation methods that will greatly
enhance the utility of this and similar models.
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1. Introduction
The cohort-component model of population projection (CCMPP) is perhaps the iconic
methodindemography, seeforexampleBowley(1924);Cannan(1895);Whelpton(1936);
Leslie (1945); Pritchett (1891); Pearl and Reed (1920); Dorn (1950). This classic method
moves incrementally forward in time a population deﬁned by age according to a speciﬁed
life table and set of age-speciﬁc fertility rates, taking into account net migration at each
age. In its basic form it is straightforward and easy to implement, which has allowed it
to become one of the essential tools used by governments and planning organizations to
help them understand the likely future size and composition of a population, and how that
may change under different assumptions or as a result of interventions of various types.
Fundamentally the CCMPP relates the age structure of a population to fertility, mor-
tality, and migration, with the current age structure being the result of fertility, mortality
andmigrationateachageinthepast. Mostcommonlyafutureagestructureofthepopula-
tion is ‘predicted’ given a time series of age-speciﬁc fertility, mortality, and net migration.
The model can also be used to estimate trends in a subset of the four components given
the others, and it is a use of this type that occupies us here.
The HIV epidemic affecting Africa and other parts of the developing world poses
signiﬁcant challenges to demographers concerned with either measuring the current state
of an affected population or predicting its future. Because HIV affects both fertility and
mortality in important ways (Sewankambo et al. 1994; Nunn et al. 1997; Carpenter et al.
1997; Gray et al. 1998; ˙ Zaba and Gregson 1998; Todd et al. 1997; Wachter, Knodel,
and Van Landingham 2002; Hunter et al. 2003; Terceira et al. 2003; Lewis et al. 2004;
Timaeus and Jasseh 2004; Ford and Hosegood 2005; Garenne et al. 2007; Gregson et al.
2007; Kahn et al. 2007; Nyirenda et al. 2007; ˙ Zaba et al. 2007; Clark et al. 2008), it is not
possible to understand the dynamics of a population affected by HIV without speciﬁcally
taking into account these effects. Further complicating this situation, data describing
underlying fertility and mortality unaffected by HIV are scarce and often of poor quality,
especially for most populations with high HIV prevalence.
These challenges are addressed in an interesting and useful way in a model developed
by Heuveline (2003). Heuveline created a multi-state version of the standard CCMPP
model (Day 1996; United Nations 2004) that further classiﬁes the population by time
since infection with HIV, and uses a set of age-speciﬁc incidence parameters to ‘in-
fect’ HIV negative people and transition them to the ﬁrst (shortest duration) HIV positive
group. This version of the model also includes additional parameters to govern the links
between HIV status and fertility. Heuveline used data describing HIV status and sur-
vival (mortality) from East African countries to estimate these model parameters, using
maximum likelihood techniques.
The purpose of this article is to build on the work of Heuveline (2003) and the multi-
40 http://www.demographic-research.orgDemographic Research: Volume 25, Article 2
state, HIV-enabled CCMPP in the following ways. Since the original publication of this
model in 2003, more data have become available on HIV prevalence and the survival
of those infected. Perhaps the most notable source of more recent data is the Demo-
graphic and Health Surveys (DHS) program (and the associated AIDS Indicator Surveys–
AIS) which have collected information on age-speciﬁc HIV prevalence from nationally-
representative population-based surveys. We augment the data compiled by Heuveline
(2003), taken from sources in East Africa, with over 100,000 observations on HIV preva-
lence provided by the DHS data in the same region.3 We estimate the model parameters
using the augmented data and compare these new estimates to those obtained by using
only the data compiled by Heuveline, as well as to the estimates obtained by using only
the more recent data compiled by us. Adding more recent data to the analysis will provide
more information about the later stages of the HIV epidemic, and the comparisons across
the data compilations will show how sensitive the estimates are to the data being used
(particularly with respect to the date when the data were collected).
Relative to the original data used, there is more recent information on the survival of
those infected with HIV (e.g. ˙ Zaba et al. 2007; Crampin et al. 2002; Urassa et al. 2001;
Sewankambo et al. 2000) which motivates an extension of the CCMPP model. Previous
work with the HIV-enabled CCMPP uses a ﬁxed survival schedule for the infected popu-
lation to estimate the model parameters (see the next section for more details). While it is
possible to specify (a priori) a reasonable survival schedule for HIV-positive individuals,
it is preferable to let data inform the model, so that the estimates and projections are not
inﬂuenced by problems with the assumed mortality experience. In this paper we extend
the CCMPP to include additional parameters that govern the survival of the infected pop-
ulation, and estimate these parameters using new data gathered from the literature. It is
worth noting that the estimated age pattern of HIV incidence may be sensitive to the life
table used for the infected population, because the incidence parameters are estimated us-
ing data on HIV prevalence, which is a function of both incidence and survival. In other
words, an observed level of HIV prevalence can arise from different combinations of in-
cidence and survival rates. Given this point, we discuss differences in the estimated age
patterns of HIV incidence between the original speciﬁcation of the model and the version
in which survival for the infected population is estimated. A ﬁnal point that motivates
our extension of the model is that the expansion of antiretroviral treatment programs will
affect the survival prospects of the infected population. The modeling techniques car-
ried out here are easily adaptable to a population with signiﬁcant access to antiretroviral
treatment, which makes CCMPP an additional tool to study the future effects of these
treatment programs.
3 The list of countries from which DHS data are used consists of Ethiopia, Kenya, Malawi, Rwanda, Tanzania,
Uganda, Zambia, and Zimbabwe.
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The ﬁnal contribution of our work is to shift the geographic focus from eastern Africa
to South Africa, where the HIV epidemic has reached even higher levels (UNAIDS 2008).
Data on age-speciﬁc HIV prevalence from a population living in a rural area of the
KwaZulu-NatalprovinceofSouthAfrica(Welzetal.2007)isusedtoestimatetheCCMPP
parameters, and these estimates are compared to those obtained from the data collected in
eastern Africa. Different parameterizations of the model are also explored along with the
long term implications for the age structure.
The subsequent sections of this paper are organized as follows. A detailed introduc-
tion of Heuveline’s multi-state, HIV-enabled CCMPP is provided in the next section, with
the Leslie matrix representation of the model. This is followed by a description of the
data and a brief discussion of the maximum likelihood estimation used in the analysis.
The focus then shifts to the results obtained from using the new data and the modeling of
the survival of the infected population. Finally, we apply the CCMPP to a rural population
in South Africa and conclude with a discussion section.
2. CCMPP
Heuveline (2003) extends the standard CCMPP to accommodate a population categorized
by duration of infection with HIV using ﬁve ‘HIV duration’ groups. There are four HIV+
duration groups (0-4 years, 5-9 years, 10-14 years, and 15+ years) as well as an HIV–
group. In this section we present Heuveline’s multi-state CCMPP for a population with
17 age groups (0-4, 5-9, ..., 80+) in each of the ﬁve HIV duration groups. The model is
introduced with a series of equations representing the transition from one group/time pe-
riod to the next. While the model can be applied to both men and women, the description
presented here only includes the details for women.
Begin by dividing the population into age groups where a = 1;2;:::;17 correspond
to age groups 0-4, 5-9, :::, 80+. Denote membership in the HIV duration groups by d,
with d = 1;2;:::;5 corresponding to HIV–, HIV+ for 0-4 years, :::; HIV+ for more
than 15 years. Time is indexed by t noting that the duration between t and t + 1 is equal
to the width of a standard age interval, i.e. 5 years. Let na;d;t be the number of women in
age group a and duration group d at time t. For 1 < a < 17, we have:
na+1;1;t+1 = na;1;t sa;1;t (1 ¡ ia;t) (1)
na+1;2;t+1 = na;1;t sa;1;t ia;t sa;2 (2)
na+1;d;t+1 = na;d¡1;t sa;1;t sa;d for d > 2 (3)
where sa;d is the survivorship ratio for age group a and duration group d. Note that
for 2 < d < 5 this survivorship ratio determines the transition from one age group to
the next, as well as from one duration group to the next. Each HIV+ group is exposed
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to the same underlying base survivorship ratio as the HIV– group, in addition to this
extra survivorship ratio that accounts for the increased mortality associated with different
durations of infection. The parameter ia;t is the fraction of women in age group a who
become infected with HIV over the projection interval. To allow for the heterogeneity of
HIV epidemics across populations, this parameter is decomposed as:
ia;k;t = 1 ¡ expf¡¡t;t0 ¢ H ¢ ja;kg (4)
where k denotes sex and ¡t;t0 is a parametric curve used to model the time trend in
the HIV epidemic from the start time t0. The actual values for ¡t;t0 are presented in
Table 1 (see the next section for more details). The parameter H is a population-speciﬁc
scale parameter that captures the overall magnitude of the epidemic. The parameter ja;k
is an age- and sex-speciﬁc scaling factor for incidence that represents the multiplicative
difference in HIV incidence between age group a and a reference age group, which is held
constant at a value of 1.0 in order to make the model identiﬁable. Following Heuveline,
we set the reference age group females aged 25-29, i.e. j5;female = 1:0.
For a given age proﬁle of incidence (a speciﬁc set of values for ja), Figure 1 demon-
strates how the different values for H simply scale the incidence proﬁle. Each panel in
this ﬁgure corresponds to a different time in the epidemic, with incidence, whose overall
scale is determined by the values of ¡. Within each panel, each line corresponds to a
value of the population-speciﬁc scale parameter H ranging from 0.1 to 1.0.
The projection equations are slightly different for the youngest and oldest age groups.
The oldest (open-ended) age group is incremented by two sources, those 75-79 and 80+
in the previous time period. Thus for a = 17 we have:
n17;1;t+1 = n16;1;t s16;1;t (1 ¡ i16;t)
+ n17;1;t s17;1;t (1 ¡ i17;t) (5)
n17;2;t+1 = n16;1;t s16;1;t i16;t s16;2
+ n17;1;t s17;1;t i17;t s17;2 (6)
n17;d;t+1 = n16;d¡1;t s16;1;t s16;d
+ n17;d¡1;t s17;1;t s17;d for 2 < d < 5 (7)
n17;5;t+1 = n16;4;t s16;1;t s16;5 + n17;4;t s17;1;t s17;5
+ n16;5;t s16;1;t s16;5 + n17;5;t s17;1;t s17;5: (8)
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Figure 1: Age-speciﬁc HIV incidence rates, ia;t, for different values of the
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As with the single-state CCMPP, the number of children in the ﬁrst age group at the
end of the projection interval is determined by surviving forward the births that occur
during the projection interval. The number of births that occur is calculated by applying
age-speciﬁc fertility rates to the average number of women in each age group during the
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projection interval, taking into account the fact that HIV+ women who have been infected
for different durations will, to varying degrees, be less likely to have children. To cap-
ture the relationship between fertility and HIV status, Heuveline deﬁned three additional

























In Equation 9 above, SRB is the sex ratio at birth, the fa;1;t’s are simply the age-speciﬁc
fertility rates for HIV– women, and the lower and upper bounds of the childbearing age
range are ® and ¯. Fertility among HIV+ women introduces the following parameters
f
¡
a;d;t = fa;1;t ea gd (1 ¡ v) (10)
for 1 < d. The superscript in f
¡
a;d;t designates HIV– births (i.e. d = 1) to women who
are HIV+. The parameter vd is the probability that an HIV+ woman in duration group
d will give birth to an HIV+ child, the vertical transmission rate. The parameter ea
captures the higher level of sexual activity and resulting fertility among HIV+ women
age 15-19 who have been infected for 0-4 years (d = 2). In other words we expect
ea=4 > 1 while ea6=4 are constrained to be 1.0. The parameter gd represents the fertility
impairment experienced by women in duration group d, a number that becomes smaller
as the time since infection increases, reﬂecting increasing fertility impairment with time
















a;d;t = fa;1;t ea gd v: (12)
Finally, we deﬁne the factors used to approximate the average number of women at the





a;1;t = sa;1;t (1 ¡ ia;t) (13)
pa;1;t = sa;1;t ia;t sa;2 (14)
pa;d;t = sa;1;t sa;d for d > 1: (15)
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2.1 The HIV incidence trend
Recall that age-speciﬁc incidence in CCMPP is modeled as follows:
ia;k;t = 1 ¡ expf¡¡t;t0 H ja;kg
where ia;k;t is the fraction of individuals age a who will become infected over the pro-
jection interval. ¡t;t0 represents the shape of the incidence trend from the start of the
epidemic in year t0 to the projection period t. This incidence trend is shifted up or down
by H, an overall scale parameter for the epidemic. Finally, ja;k is the incidence ratio
comparing those of age a and sex k to women age 25-29. The details of the incidence
trend ¡t;t0 are described in this section, along with several other possible speciﬁcations.
The incidence trend ¡t;t0 used by Heuveline (2003) is borrowed from EpiModel,
a computer program developed by the World Health Organization to make short-term
projectionsofadultAIDScases(ChinandLwanga1991)(theprecursorofEPP,UNAIDS’
estimation and projection package software used to estimate the prevalence of HIV (Ghys
et al. 2004)), and is based on the gamma family of distributions:
g(t) =
t®¡1e¡x=¯
(® ¡ 1)!¯®; for t ¸ 0; ® > 0 ¯ > 0: (16)
The® parameteris typicallyreferred to asthe shapeparameter since itaffectshowpeaked
or ﬂat the density is; as ® increases the density appears more ﬂat or uniform. The scale
parameter ¯ is associated with how diffuse or spread out the density is; as ¯ increases the
density spreads out.
Before discussing the calculations made by Heuveline (2003) it is helpful to discuss
a particular property of the gamma distribution. The mode, or the the value for which
the the function reaches its maximum, is equal to (® ¡ 1)¯. This quantity has a nice
interpretation in that it is the number of years after the start of the epidemic t0 when the
epidemic peaks. For example, if the shape parameters is 5 and the scale parameter is 3,
then the epidemic peaks 12 years after it began.4
4 ChinandLwanga(1991)reportthatsetting® = 5resultsin “thebestempirical‘ﬁt’to thereportedAIDS-case
curves in countries with reliable case-reporting systems.” They set ¯ = 1.
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This is precisely the density used by Heuveline (2003) to calculate the ﬁve-year inci-
dence rates (i.e. ® = 5;¯ = 3). The actual rates are calculated by integrating the gamma





(5 ¡ 1)!35dt for 5 ¸ x · 20; (17)




(5 ¡ 1)!35dt: (18)
The ﬁve-year incidence rate for twenty years after the start date is different because the
decline in the gamma density for values greater than 20 is too rapid to represent an actual
decline in incidence. The values used to estimate the CCMPP parameters are presented
in Table 1. We are aware that this is relatively crude, and it would be preferable to model
this trend using time series techniques with attention given to the uncertainty around the
trend, especially at time points far into the future. That is among the improvements that
currently occupy us.
Table 1: Five-year incidence rates calculated from the gamma density and
an exponential curve
Time Period ¡t; t0 Et; t0
0 - 5 years 0.028 0.063
6 - 10 years 0.216 0.191
11 - 15 years 0.316 0.323




a For the gamma model it is assumed that the HIV incidence rate will level off at the rate equal to the integral
of the gamma density from 20 and 21 multiplied by ﬁve. For the exponential model it is assumed that the
HIV incidence rate will level off at a rate equal to 5¤(h(t = 21)¡h(t = 20)). See the text for the deﬁnition
of h(t).
We will now discuss two other possible speciﬁcations for the trend in HIV incidence.
The ﬁrst is an exponential curve that models a continual increase in HIV over time. While
this may not be realistic in the long run, it does provide an upper bound for the trend. A
reasonable lower bound is a constant rate of new infections (i.e. no change) over time.
Since the second speciﬁcation is simply a constant5 we will focus our attention on the
exponential model.
5 Heuveline (2003) uses 0.2 as the ﬁve-year incidence rate.
http://www.demographic-research.org 47Thomas & Clark: More on the cohort-component model of population projection in the context of HIV/AIDS





¡ t for t = 1;2;3;:::; and ¯ > 0: (19)
The ﬁve-year HIV incidence rates are calculated by differencing h(t) (at lag one) and




h(t) ¡ h(t ¡ 1) (20)
Heuveline (2003) chooses a value of ¯ = 0:005 to obtain the ﬁve-year HIV incidence
rates based on the exponential model, shown in Table 1. Finally, similar to the gamma
model described above, the incidence rate after twenty years takes a different form. For
the exponential curve, E20+;t0 = 5 £ (h(t = 21) ¡ h(t = 20)).
2.2 Additional HIV-related force of mortality
In the HIV-enabled CCMPP individuals infected with HIV (d > 1) experience an addi-
tional force of mortality that is not experienced by those in the HIV– state (d = 1). This
mortality differential can be seen in the following projection equations
na+1;d=2;t+1 = na;d=1;t sa;d=1;t ia;t sa;d=2 (21)
na+1;d>2;t+1 = na;d¡1;t sa;d=1;t sa;d>2 (22)
where sa;d>1 < 1; survival in the HIV+ states is reduced compared to the HIV– state.
Recall that the vital rates in CCMPP are treated as ﬁxed parameters and need to be set by
the user.
Heuveline turns to the epidemiological literature for guidance on choosing values for
the survival rates of individuals infected with HIV. One of the more important ﬁndings
(concerning the HIV-enabled CCMPP) is that the progression from HIV to death is faster
for those infected at older ages. Morgan et al. (2002) report this ﬁnding in a cohort study
in rural Uganda for whom the time of HIV infection is reasonably well known, and the
median follow-up time is 5.6 years (interquartile range: 3.6-7.3 years). Among those
aged 15-24, 25-39, and 40+ years at seroconversion, the probabilities of surviving seven
years (after seroconversion) are 79% (95%CI: 63-88%), 72% (95%CI: 56-83%), and 20%
(95%CI: 6-40%), respectively. These estimates are based on 10, 18, and 19 deaths among
65, 68, and 35 participants, going from the youngest to the oldest age group. Morgan et al.
(2002) also report a faster progression from seroconversion to AIDS for the oldest age
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group (40+ years).6 Similar results are reported in an updated analysis of these Ugandan
data by Van der Paal et al. (2007), and in other cohort studies carried out in sub-Saharan
Africa (Lutalo et al. 2007; Isingo et al. 2007; Murray et al. 2007).
Given the evidence from the epidemiological literature, Heuveline (2003) speciﬁes
the survival rates for HIV+ individuals as a function of age at infection. This dependence
comes through in the choice of a particular survival schedule, deﬁned by the median
number of years lived after infection. The schedules include median survival times of 3,
8, 10, and 12 years, which is consistent with the empirical evidence from sub-Saharan
Africa (Newell et al. 2004; Marston et al. 2005; Morgan et al. 2002; Van der Paal et al.
2007; Lutalo et al. 2007; Peters et al. 2007; Isingo et al. 2007). Children who are infected
perinatally follow the 3 year schedule, while the oldest age groups follow the 8-year
schedule. Before describing the age dependence in greater detail, it is helpful to take a
slight digression and deﬁne some more notation.
Heuveline (2003) deﬁnes these survival schedules with reference to the projection
interval (i.e. ﬁve years). Let yd;m be the expected number of years lived by an individual
in duration group d following survival schedule m, where m = 3;8;11;12. For example,
the average number of years lived by a person infected 5-9 years ago who is following the
survival schedule with a median survival time of 11 years is yd=3;m=11 = 3:375. The
values for yd;m are listed in Table 2.
Table 2: Expected number of person-years lived over a ﬁve-year interval by
survival schedule and duration group
Survival Schedule
Duration Group 3 8 11 12
0 to 0-4 (d=2) 2.7750 4.7100 4.8000 4.8310
0-4 to 5-9 (d=3) 0.4250 2.4300 3.3750 3.6000
5-9 to 10-4 (d=4) 0.0000 0.8600 2.0000 2.4125
10-4 to 15-9 (d=5) 0.0000 0.3150 1.0000 1.5375
Now we are in a position to deﬁne sa;d>1. Let us begin with those who have been
infected for 0-4 years (d = 2). Children born and infected (perinatally) during the projec-





6 In this same study, the median time from seroconversion to AIDS is 9.4 years, IQR: 5.5 – 10.1 years. The
median time from seroconversion to death is 9.8 years, IQR: 6.1 – > 10.3 years (Morgan et al. 2002).
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The HIV-related survival ratios for the next two age groups are deﬁned to be 1.0 because
persons between the of ages 5 and 9 are not able to be infected given our current assump-
tions about incidence. Recall that the age-speciﬁc incidence rates are zero for the ﬁrst
three age groups.7 For those who are ages 15-19, 25-34, or above age 45, the additional
force of mortality caused by HIV takes a form similar to the equation just above:
sa=4;d=2 =
yd=2;m=12
5 = 0:9662 (24)
s8¸a¸6;d=2 =
yd=2;m=11
5 = 0:9600 (25)
sa¸10;d=2 =
yd=2;m=8
5 = 0:9420: (26)
Note how survival declines as age increases before leveling off at age 45 and above. For
the age groups not already mentioned, the survival parameters are calculated by taking
the average over two adjacent survival schedules:
sa=5;d=2 =
yd=2;m=11+yd=2;m=12
2 = 0:9631 (27)
sa=9;d=2 =
yd=2;m=8+yd=2;m=11
2 = 0:9510: (28)
We now turn our attention to the third duration group, individuals who have been





The corresponding parameters for the older age groups take a similar form. The expected
number of years lived for the third duration group is divided by the expected number of
years lived by the second duration group (for a given survival schedule). The dependence
on age for d = 3 takes the same form as for the previous duration group, only that the age





















7 This might not be the best assumption since infants are still able to become infected via breastfeeding.
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The pattern continues for the fourth and ﬁfth duration groups. All of the parameters for
the additional force of mortality due to HIV are listed in Table 3.
Table 3: Survival probabilities applied to HIV+ (sa;d>1)
HIV Duration Group
Age Group 0-4 yrs 5-9 yrs 10-4 yrs 15+ yrs
(d=2) (d=3) (d=4) (d=5)
0-4 0.5550 – – –
5-9 – 0.1532 – –
10-4 – – 0.0000 –
15-9 0.9662 – – 0.0000
20-4 0.9631 0.7452 – –
25-9 0.9600 0.7242 0.6701 –
30-4 0.9600 0.7031 0.6326 0.6373
35-9 0.9600 0.7031 0.5926 0.5751
40-4 0.9510 0.7031 0.5926 0.5000
45-9 0.9420 0.6104 0.5926 0.5000
50-4 0.9420 0.5159 0.4927 0.5000
55-9 0.9420 0.5159 0.3539 0.4598
60-4 0.9420 0.5159 0.3539 0.3663
65-9 0.9420 0.5159 0.3539 0.3663
70-5 0.9420 0.5159 0.3539 0.3663
75-9 0.9420 0.5159 0.3539 0.3663
80+ 0.9420 0.5159 0.3539 0.3663
Life tables can also be constructed using the survival rates presented in Table 3, where
cohorts deﬁned by age at infection are exposed to the survival rates aligned along the
diagonal cells of the table. For example children infected by their mothers will never
reach age 15 years because the survival probability is zero for those infected at birth
and between the ages of 10 and 14. The mortality experienced by the cohort of women
infected at age 15 is summarized in the life table presented in Table 4.
The size of the cohort exposed to the mortality risks in Table 4 is reduced to half
after ﬁfteen years. After thirty years there is just under ten percent of the cohort still
living. While the survival experience of this cohort may seem plausible, it is preferable to
have the their survival rates informed by data. The current speciﬁcation for the survival
experience results in a stable population with unappealing characteristics. This point is
discussed later on in the paper.
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Table 4: Life table for HIV+ women infected at age 15
Age group npx nqx lx ndx nLx Tx
0
e
15 0.9566 0.0434 100,000 4,345 489,138 1,612,020 16.1202
20 0.7347 0.2653 95,655 25,381 414,822 1,122,882 11.7389
25 0.6587 0.3413 70,274 23,983 291,412 708,060 10.0757
30 0.6255 0.3745 46,291 17,338 188,110 416,648 9.0006
35 0.5634 0.4366 28,953 12,642 113,160 228,538 7.8934
40 0.4883 0.5117 16,311 8,346 60,690 115,378 7.0736
45 0.4863 0.5137 7,965 4,092 29,595 546,880 6.8660
50 0.4823 0.5177 3,873 2,005 14,352 25,093 6.4789
55 0.4370 0.5630 1,868 1,052 6,710 10,741 5.7498
60 0.3388 0.6612 816 540 2,730 4,031 4.9395
65 0.3220 0.6780 276 187 912 1,301 4.7125
70 0.2940 0.7060 89 63 288 389 4.3669
75 0.2500 0.7500 26 20 80 101 3.8713
80 0.1586 0.8414 6 6 21 21 3.4425
2.3 Matrix notation for HIV-enabled CCMPP
These equations for the multi-state, HIV-enabled CCMPP can be conveniently expressed
in matrix notation. For a population with 17 age groups and ﬁve HIV duration groups, the
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B1;1 B1;2 B1;3 B1;4 B1;5
B2;1 B2;2 B2;3 B2;4 B2;5
0 B3;2 0 0 0
0 0 B4;3 0 0







where Bi;j is a 17£17 sub-matrix that models how group j at time t contributes to group
i at time t+1. Note that B3;1 is a zero matrix since women who are HIV– at time t cannot
give birth to children who have been HIV positive for ten years by t + 1 (i.e. ﬁve years
into the future). Similar reasoning applies for the other zero matrices.
The calculations involving B1;j produce the projection for the number of HIV– births
(i.e. n1;1;t+1) contributed by duration group j. Similarly, B2;j projects the number of
HIV positive births contributed by duration group j > 1. B1;1 and B2;1 are a little
different in that they project each age group to the next oldest age group and from one





















































Recall that the number in the ﬁrst age group at time t + 1 is equal to the number of births
summed across the fecund age groups. Let b
¡
a;d;t be the factor needed to calculate the
















In our application of the multi-state, HIV-enabled CCMPP, fertility only occurs among




a>10;1;t = 0. In
the equation above the factor
na¡1;1;t
na;1;t is used to approximate the number of women at risk
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of giving birth. If the count in the denominator na;1;t is ever zero the entire ratio is simply
replaced by zero. This issue arises when dealing with the fertility of the HIV+ groups.
The same procedure is used in the analogous HIV+ equations if they involve dividing by
zero.

















































for d > 1. The B2;d’s determine the number of people infected with HIV for less than
ﬁve years at time t + 1, contributed by those in duration group d at time t. For the ﬁrst
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B2;d for d > 1 projects forward the number of HIV+ births contributed by duration










































The remaining non-zero sub-matrices – B3;2;B4;3;B5;4 and B5;5 – project people








































The Leslie matrix representation of the model greatly facilitates the implementation
and use of the multi-state, HIV-enabled CCMPP using the R programming language (R
Development Core Team 2011). Repeated matrix multiplication produces the projected
population at ﬁve-year intervals, making it possible to explore the long term behavior of
the population and the epidemic. See the results section for an application to a population
living in the KwaZulu-Natal province of South Africa. Finally, if the Leslie matrix is
irreducible and primitive, then we can explore the stable age distribution of the population
(Keyﬁtz and Caswell 2005).
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3. Parameter estimation
The CCMPP projections are used to estimate thirty-three of the model parameters. As
mentioned earlier, the vital rates, the initial population counts and the HIV survival sched-
ules are all ﬁxed. The 33 parameters we estimate are:
² v: vertical transmission parameter that is constrained to be between 0 and 1; al-
though the model is described as having a vertical transmission rate for each dura-
tion group, there are not enough data to estimate separate parameters. (1 parameter)
² ea: fertility selection parameter that is constrained to be equal to 1 for all groups
except women aged 15-19 in the ﬁrst HIV duration group, for whom we expect the
value to be greater than 1. (1 parameter)
² gd: fertility impairment parameter for women in duration group d, for d = 2;3;4;
the fertility impairment parameter for d = 5 is constrained such that gd=5 = gd=4,
and the values for all duration groups are constrained to be between 0 and 1. (3
parameters)
² ja;k: relative incidence ratio parameter that is constrained to be equal to 1 for
women age 25-29 and non-negative for all other groups; values are estimated for
women (k = 1) age 15 ¡ 19;20 ¡ 24;30 ¡ 34;35 ¡ 39;:::;55 ¡ 59 and for men
(k = 2) in the age groups between 15-59 (i.e. 8 and 9 age-speciﬁc parameters for
women and men, respectively). (17 parameters)
² Hh: scale parameters for the trend in HIV incidence for population h. (11 parame-
ters)
For a given set of parameter values, we obtain a set of not necessarily unique age- and
sex-speciﬁc counts. These model outputs are used to calculate predicted values for the
observed data. For example the ratio of the projected number of HIV+ women age 20-
25 over the total number of women projected in that age group, is used to predict the
observed HIV prevalence for women in that age group. Several types of observed data,
such as HIV prevalence, are used to estimate the values of the parameters that are most
likely.
In this section we discuss this topic in greater detail. The ﬁrst focus is on the types
of data used in the analysis. We then shift to the likelihoods speciﬁc to each type of
data. Finally we turn to the techniques used to estimate the parameters, namely maximum
likelihood (ML) estimation.
3.1 Data types
Heuveline (2003) uses data published in the literature to estimate the model parameters.
These data consist of observations from eleven different East African populations col-
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lected from antenatal clinics (ANCs), demographic surveillance sites, hospitals and gen-
eral surveys. Both rural and urban areas are included, and the years of data collection
range from 1989 to 1998. The data are classiﬁed into the following ﬁve categories (see
Table 1, Heuveline 2003):
1. HIV test results in a general-population sample (10 data sets)
2. HIV test results in an ANC-patient sample (3 data sets)
3. HIV test results in all or a sample of births from HIV+ mothers (3 data sets)
4. HIV test results during a follow-up of an HIV– sample (3 data sets)
5. Survival during a follow-up of HIV+ individuals (3 data sets)
In addition to the data compiled by Heuveline, several new sources are also included in
the analysis carried out here. All of the data sources are listed in Table 5, with the sources
unique to the current analysis appearing in the shaded rows.
Although we have updated the information used to estimate the CCMPP parameters,
we are unable to exploit many of the published results in the literature because those
data are not broken down by age. For example, vertical transmission and the subsequent
survival of infected infants has been the focus of a great deal of research (e.g. Simonon
et al. 1994; Miotti et al. 1999; Spira et al. 1999; Nicoll et al. 2000; De Cock et al. 2000;
Nduati et al. 2000; Mandelbrot et al. 2002; Petra Study Team 2002; Jackson et al. 2003;
Read and Breastfeeding and HIV International Transmission Study Group 2004; Newell
et al. 2004; Zijenah et al. 2004; Marston et al. 2005; Brahmbhatt et al. 2006; Kagaayi et al.
2008). While much has been learned from these studies, the published information is not
stratiﬁed by the age of the mother, which would allow us to estimate the rate of vertical
transmission by HIV duration groups. Without this level of detail, the CCMPP estimate
of the vertical transmission rate is simply an average across all the estimates weighted
by sample size. If future studies in this area tabulate the data by age of the mother it
would greatly beneﬁt modeling efforts.8 Similarly, many of the results concerning the
survival of infected individual (e.g. Van der Paal et al. 2007; Lutalo et al. 2007; Smith
et al. 2007; Peters et al. 2007; Isingo et al. 2007; Murray et al. 2007), as well as HIV
incidence and prevalence rates (e.g. Urassa et al. 2006; ˙ Zaba et al. 2000; Wambura et al.
2007) are not reported by age.9 Small sample sizes may be a limiting factor, but we
encourage future studies to report age-speciﬁc results whenever possible so that others
can utilize the patterns observed along this critical dimension.
8 The median survival time of children infected with HIV is around two years (Newell et al. 2004). Thus,
the CCMPP model, which classiﬁes the population into ﬁve-year age groups, can contribute very little to this
question.
9 Age-speciﬁc results are available for other geographic regions (e.g. Nyirenda et al. 2007), but we restrict our
focus to countries in East Africa.
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Table 5: Descriptions for each source that contributes data used in the




Year of Start Urban/
Type Data Year of Rural
Collection Epidemic
Burundi Bujumbura 1 Saidel et al. (1996) 1990 1973 Urban
Bujumbura 2 Sokal et al. (1993) 1991-2 1973 Urban
Bujumbura 4 Saidel et al. (1996) 1991 1973 Urban
Ethiopia national 1 DHS/AISa 2005 1980 National
Kenya Mombasa 1 Hawken et al. (2002)a 2000 1974 Urban
national 1 DHS/AISa 2003 1980 National
Malawi Mangochi 2 Slutsker et al. (1994) 1990 1975 Urban
Karonga 1 McGrath et al. (2007)a 2005 1975 Rural
Karonga 2 Crampin et al. (2008)a 1994-2001 1975 Rural
Karonga 5 Crampin et al. (2002)a 1998-2000 1975 Rural
Blantyre 2 Taha et al. (1998)a 1990, 1995 1975 Urban
national 1 DHS/AISa 2004 1980 National
Rwanda national 1 DHS/AISa 2005 1976 National
Tanzania Mara 1 Shao et al. (1994) 1990 1975 Urban
Mwanza 1 Grosskurth et al. (1995) 1992 1975 Rural
Mwanza 1 Mwaluko et al. (2003)a 1994, 1999 1975 Rural
Mwanza 4 Boerma et al. (1999)a 1994-7 1975 Rural
Mwanza 5 Urassa et al. (2001)a 1994-8 1975 Rural
Mwanza 5 Todd et al. (1997) 1994 1975 Rural
Kagera 1 Kwesigabo et al. (2005)a 1987, 1996 1975 Urban
Kagera 1 Kwesigabo et al. (2005)a 1996 1975 Rural
national 1 DHS/AISa 2004, 2007 1980 National
Uganda Fort Portal 1 Kilian et al. (1999) 1995 1975 Urban
Gulu 2 Fabiani et al. (2001) 1993, 1997 1975 Rural
Masaka 1 Nunn et al. (1994) 1989 1975 Rural
Masaka 2 Carpenter et al. (1997) 1990 1975 Rural
Masaka 4 Kengeya-Kayondo et al. (1996) 1990-4 1975 Rural
Masaka 4 Shafer et al. (2008)a 1995-2005 1975 Rural
Masaka 5 Nunn et al. (1997) 1990 1975 Rural
Rakai 1 Wawer et al. (1991) 1989-91 1980 Rural
Rakai 4 Wawer et al. (1994) 1990 1980 Rural
Rakai 1 Serwadda et al. (1992) 1989-91 1980 Rural
Rakai 2 Gray et al. (1998) 1995 1980 Rural
Rakai 5 Sewankambo et al. (1994) 1980 1990 Rural
Rakai 5 Sewankambo et al. (2000)a 1994-8 1980 Rural
Nsambya &
Jinja
2 Asiimwe-Okiror et al. (1997)a 1990 1975 Urban
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Table 5: (Continued)
Country City/Town
Data Citation Year of Start Urban/





2 Asiimwe-Okiror et al. (1997)a 1995 1975 Urban
national 1 DHS/AISa 2004 1980 National
Zambia Chelston 1 Fylkesnes et al. (1998) 1995 1975 Urban
Kapiri Mposhi 1 Fylkesnes et al. (1998) 1996 1980 Rural
Lusaka 3 Hira et al. (1989) 1987 1975 Urban
national 1 DHS/AISa 2002,2007 1976 National
Zimbabwe Mutasa 1 Gregson and Garnett (2000) 1998 1977 Rural
Manicaland 1 Gregson et al. (2002)a 2000 1976 Rural
national 1 DHS/AISa 2006 1980 National
Data types: (1) HIV test results in a general-population sample;
(2) HIV test results in an ANC-patient sample;
(3) HIV test results in all or a sample of births from HIV+ mothers;
(4) HIV test results during a follow-up of an HIV– sample;
(5) Survival during a follow-up of HIV+ individuals
Notes: The data sources that are unique to the current analysis appear in the shaded rows.
a New sources of data not included in the compilation used by Heuveline (2003). DHS/AIS refers to the
Demographic and Health Survey program and the AIDS Indicator Surveys.
It should be noted that the CCMPP also requires vital rates for the uninfected popula-
tion and an initial age distribution. These model inputs are taken from the United Nations
global population estimates (United Nations 1999) and model life tables (United Nations
1982).
3.2 Likelihoods
Each category of data provides the pieces needed for a proportion which leads to the use







¼x(1 ¡ ¼)N¡x (45)
where N is the total number of events, x is the number of “successes”, ¼ is the proba-
bility of success, and the product is taken over age, sex, the data types, and the various
populations. The ﬁrst two quantities N and x are taken from the data and we use CCMPP
to calculate ¼ given values for the parameters.
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Before discussing the ﬁner details of how the CCMPP outputs are used in the like-
lihood, it is important to cover two points. First, we need to temporally match up the
CCMPP projections with the observed data. The start year for the model is the year when
widespread transmission of HIV began, t0. The population is then projected forward to
the year when the data were collected. For example if widespread transmission in a coun-
try began in 1980 and the observed data are from 2000, then we can take the projected
counts 20 years from the start time and compare these to the observed data. Given that
the projections are in ﬁve year increments, it is sometimes necessary to take the average
across two projection periods to match the year of data collection. Estimates of when
widespread HIV transmission began are taken from a report by the United Nations (1998,
Table 1).
Second, the data come from populations at twenty-six different locations.10 At a
given location there can also be several different types of data. For example data from
the population living in Mwanza, Tanzania, include both HIV prevalence from a general
populationandsurvivalinformationforthosewhoareHIV+. Asaresultthereisaseparate
likelihood for the 51 combinations of location, year, and data type retrieved from the
literature. These are indicated using h for the population (and location) and c for the type
or category of data. Finally, the data consist of sex- and age-speciﬁc information so the
likelihoods may also be indexed by these characteristics as well.
3.2.1 HIV test results in a general-population sample
Various studies have collected data on sex- and age-speciﬁc HIV prevalence in a sample
from the general population. The age groups range from 15-19 to 55-59. This type of
data, labeled ‘1’ (c = 1), usually includes the number of people tested and the percent
who tested positive for HIV by sex and age. The likelihood, however, requires a count of
individuals who are HIV+, so we calculate this quantity from the data and round it to the
nearest integer. Let Na;k;t;h;c =1 denote the total number of individuals in age group a of
sex k at time t at location h and let xa;k;t;h;c =1 be the number in this group who tested
positive.
10 See Table 5 for the locations.
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na;d;t;h the projected counts from CCMPP are used to predict sex- and age-speciﬁc







where the sum is taken across HIV duration groups. Having chosen the projection period
that matches up with the year the data were observed, we can use ¼a;k;t;h;c =1 in the
binomial likelihood. A ﬁnal note is that the observed data may be reported by age groups
that do not match those of our projections. In this case weighted sums of the projected
counts can be used to estimate HIV prevalence. For example if observed prevalence is
reported for individuals age 17-25, then predicted prevalence can be calculated as:
¼age=(17¡25);k;t;h;c=1 =
P5
d=2(na=4;d;t;h £ 0:6 + na=5;d;t;h)
P5
d=1(na=4;d;t;h £ 0:6 + na=5;d;t;h)
: (47)
This issue arises with the other data types as well.
3.2.2 HIV test results in an ANC-patient sample
Seven of the data sets used in this analysis provide age-speciﬁc information on HIV preva-
lence for female attendees of ANCs, typically from age 15 to 49. This type of data,
indexed by c = 2, takes a form similar to the observed prevalence from a general pop-
ulation, except that they only refer to women. Both the total number of women tested
Na;k =1;t;h;c=2 and the age-speciﬁc prevalence are reported. The data are included in the
binomial likelihood as counts, so we calculate the number of women who tested positive
xa;k =t;h rounded to the nearest integer.
The predicted prevalence for the ANC attendees is calculated differently than for the
general population. Recall that there are two primary assumptions of CCMPP concerning
the fertility of HIV+ women. The ﬁrst is that HIV+ women age 15-19 have higher fertility
which is captured by the fertility selection parameter ea=4. Second, fertility is expected
to decline as time since infection increases, modelled by the fertility impairment param-
eters gd>1. Since the HIV+ women observed in the data are pregnant, these parameters
are included in the calculation of predicted prevalence. The formula is:
¼a;k =1;t;h;c=2 =
P5
d=2 na;d;k=1;t;h £ ea £ gd
na;d;k =1;t;h +
P5
d=2 na;d;k =1;t;h £ ea £ gd
; (48)
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where the sum is taken over the duration groups. Having chosen the projection period
that matches up with the year the data were observed, we can use ¼a;k =1;t;h;c=2 in the
binomial likelihood.
3.2.3 HIV test results in all or a sample of births from HIV-positive mothers
Heuveline (2003) found three data sets consisting of information on the fertility of HIV+
women. However one of these sources, Hira et al. (1989), differs from the others in that it
provides information on whether or not an HIV+ mother infected her child. Data from the
other two sources, Carpenter et al. (1997) and Gray et al. (1998), consist of the number
of children born to both HIV+ and HIV– women, by age group. The likelihoods for the
latter two sources are nearly identical to those in the data category c = 2, HIV test results
in an ANC sample. The only difference is that the observed counts (i.e. the data) refer to
the total number of children born to female ANC attendees in a speciﬁc age group, and
the number of children born to HIV+ attendees. The probability that a child is born to
an infected mother is calculated in exactly the same way as ¼a;k =1;t;h;c=2. Given this
similarity the data reported by Carpenter et al. (1997) and Gray et al. (1998) are classiﬁed
here as c = 2.
Data that take the form of Hira et al. (1989) will also be indicated by c = 3. The
corresponding counts used in the likelihood refer to the total number of children born
to infected mothers in age group o, No;t;h;c=3, and the number of these children who
are infected by their mothers xo;d=2;t;h;c=3. The predicted rate of vertical transmission
using the model outputs is calculated as:
¼o;t;h;c=3 =
P5
d=2 na;k=1;d;t;h £ fa;d=1;t;h £ ea £ gd £ vd
P5
d=2 na;k=1;d;t;h £ fa;d=1;t;h £ ea £ gd
; (49)
where the sum is taken over the duration groups.
Unfortunately, this leaves only one data source to inform the estimate of the verti-
cal transmission parameter. This issue is especially problematic when the parameter is
constrained to be equal across duration groups (i.e. vd = v, for all d). Note that all the
like terms in the numerator and denominator cancel out, so the projections have no in-
ﬂuence on the likelihood. Thus including more data of this type would be beneﬁcial for
future analysis using this model. As mentioned earlier, a substantial amount of the pub-
lished data on vertical transmission does not stratify the information by age of the mother,
which prevents us from utilizing these data to estimate the CCMPP parameters. Without
this level of detail, the CCMPP estimate of the vertical transmission rate is simply an
average across all the estimates weighted by sample size.
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3.2.4 HIV test results during a follow-up of an HIV-negative sample
Data on sex- and age-speciﬁc HIV incidence are also used to estimate CCMPP parame-
ters. These data indexed by c = 4 are typically reported in terms of the number of people
who become infected and the total number of person-years lived while uninfected. For
the binomial likelihood however, we need the counts of the initial population observed
Na;t;d=1;t;h;c=4 and the number who become infected Xa;t;d=2;t;h;c=4. Thus the ini-
tial population size needs to be calculated from the observed data, and this calculation can





¡T £ # Converted
Person-Years
o (50)
where T is the total number of years observed.11
The model outputs are then used to calculate the probability of becoming infected for
men or women in a certain age group at a given location and time. That is:
¼a;k;d=1;t;h;c=4 =
na;k;d=1;t;h £ sa;k;d=1;t;h ¡ na+1;k;d=1;t+1;h
na;k;d=1;t;h £ sa;k;d=1;t;h
(51)
where ¼a;k;d=1;t;h;c=4 is the proportion of HIV– women/men who become infected after
ﬁve years. As discussed earlier, the period of observation for the data may not be equal to
the projection interval of ﬁve years. If the observation period is only four years, then the












3.2.5 Survival during a follow-up of HIV+ individuals
The ﬁnal category of data describes the survival (mortality) of HIV+ individuals. This
category indexed by c = 5 is similar to the previous one in that the data reported include
the number of deaths observed among a cohort of HIV+ individuals of a particular age
and sex Xa;k;t;h;c =5 and the number of person-years observed for each group. As be-
fore, the likelihoods require the initial population size for each group Na;k;t;h;c =5 (see
Equation 50). These two inputs Xa;k;t;h;c =5 and Na;k;t;h;c =5 are the counts needed for
11 In deriving this equation it is helpful to note that the number of person-years lived by a population of initial
size N0 and of size NT T years later is equal to
(NT ¡N0)£T
log(NT =N0) .
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the binomial likelihood with the corresponding proportion referring to the probability of
death over a given period of time.
The procedure for calculating the probability of death from the model outputs is best
described in two steps. First, we calculate the probabilities by age, sex, and duration
group. This can be written as:






for d ¸ 2 (53)
where T is the number of years over which the data were observed. Since the observed
data do not contain information on duration group, we must calculate the weighted av-




d=2 qa;k;d;t;h;c =5 £ na;k;d;t;h
na;k;d;t;h
: (54)
This is the probability used in the binomial likelihood.
3.3 Parameter estimation
A maximum likelihood (ML) approach is used to estimate the most likely parameter val-
ues(giventhedataandthemodel)andtheuncertaintyaroundthosepointestimates. Given
the data from an individual site, the likelihood of a speciﬁc set of CCMPP parameter val-
ues can be calculated using the binomial expressions described above. There are twenty-
two likelihoods in the original data compilation and an additional twenty-nine likelihoods
included in the analysis below. We follow Heuveline (2003) and combine these likeli-
hoods by taking the product across all locations and data types, assuming independence.
The set of parameter values that maximizes the combined likelihood is the ML point esti-
mate.
The ML estimation as well as the implementation of CCMPP is performed using the
R programming language (R Development Core Team 2011). This languages provides an
optimization routine optim that is used to ﬁnd the parameter values that maximize the
combined likelihood described above. In addition optim calculates the Hessian matrix
of the likelihood function at the maximum. Standard errors are obtained by inverting the
Hessian matrix (after multiplying it by negative one) and taking the square root of the
diagonal elements.
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4. Results
Five sets of ML estimates for the CCMPP parameters are presented in Table 6, with the
95% conﬁdence intervals shown in parentheses. The ﬁrst column of estimates (moving
from left to right) contains the results published by Heuveline (2003) and the second col-
umn lists our replication of his work using the same data. The point estimates for these
two sets of results are generally consistent, as is seen with the vertical transmission rate.
In both of the analyses it is estimated that 38.5% of children born to HIV+ mothers will
be infected by their mothers, with the conﬁdence intervals reaching from a low of around
30% to a high of nearly 48%. This result is well in line with previous estimates of verti-
cal transmission in sub-Saharan Africa that range from 25% to 45% (Nicoll et al. 2000;
Marston et al. 2005).12 Both sets of results also suggest that infected women 15 to 19
years old have fertility that is considerably higher than HIV– women in the same age
group. The multiplicative factor by which fertility is higher among infected women is
equal to the early-selection fertility coefﬁcient times the fertility impairment coefﬁcient
for women infected less than ﬁve years. These factors are 1.42 for Heuveline’s estimates
and 1.39 for our replication of his analysis using the same data. The fertility of women
infected for ﬁve or more years is estimated by Heuveline to be lower than that of un-
infected women or those infected for less than ﬁve years. Our results are consistent in
that the fertility of women who have been infected for 5 to 9 years is likely to be at least
40% lower than uninfected women (i.e. the upper bound of the 95% conﬁdence inter-
val is 0.60). However, the large amount of uncertainty around the fertility impairment
coefﬁcient for women who have been infected for 10 or more years makes it difﬁcult to
draw conclusions about the fertility experience of these women. Finally, our estimated
age patterns of HIV incidence, for both women and men, are similar to those reported by
Heuveline (2003). Among women the risk of infection is highest for those 20 to 24 years
old, then the relative incidence ratios decline with age. There is a similar pattern for men,
but the estimated risk of infection peaks at an older age group, those 25 to 29 years old.
Although our estimate of the relative incidence ratio for men 15 to 19 years old is higher
than that of Heuveline and our 95% conﬁdence intervals tend to be wider,13 we feel that
our results are similar enough to Heuveline’s to justify using our implementation of the
model to analyze the new data.14
12 These estimates are higher than the 20% reported by Newell et al. (2004) from an analysis of data pooled
across sub-Saharan Africa, but the infection status of 17% of the children was undetermined.
13 It is worth noting that some of our 95% conﬁdence intervals include negative values, which is troubling given
that zero is the natural lower bound for the parameters. The same is true for the upper bound, namely 1.00, of
the duration-speciﬁc fertility impairment coefﬁcient for women infected for 0 to 4 years (5 to 9 years) when
using gamma trend with the new data (all of the data) to estimate the parameters.
14 For a given set of model inputs, our population projections match exactly those made by Heuveline. This
suggests that differences between the two types of software (Microsoft Excel and R) used to carry out the
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Table 6: Maximum likelihood estimates of the CCMPP parameters for the
original data sources compiled by Heuveline (2003), the new data
sources only, and all of the data sources combined
Heuveline Thomas & Clark
Original Original New Data All
Parameters Data Data Gamma Constant Data
Vertical Transmission
Rate (%) 38.5 38.5 – – 38.5
(29.7, 47.8) (29.3, 47.7) – – (29.4, 47.6)
Early-Selection Fertility
Coefﬁcient 1.672 1.538 – – 1.954
(1.492, 1.865) (1.028, 2.048) – – (1.578, 2.330)
Duration-Speciﬁc Fertility
Impairment Coefﬁcients
0-4 years 0.848 0.905 – – 0.749
(0.798, 0.909) (0.664, 1.146) – – (0.576, 0.922)
5-9 years 0.357 0.245 – – 1.00
(0.276, 0.450) (-0.1, 0.59) – – (0.749, 1.251)
10 years and above 0.293 0.461 – – 0.433
(0.078, 0.607) (-0.027, 0.949) – – (0.138, 0.728)
Female Age-Speciﬁc
Relative Incidence Ratio
15-9 0.594 0.585 0.762 0.564 0.849
(0.545, 0.650) (0.471, 0.698) (0.672, 0.852) (0.504, 0.623) (0.738, 0.960)
20-4 1.325 1.297 1.496 1.183 1.255
(1.239, 1.412) (1.04, 1.553) (1.279, 1.712) (1.038, 1.328) (1.499, 1.744)
25-9 (referent) 1.000 1.000 1.000 1.000 1.000
– – – – –
30-4 0.752 0.724 0.922 0.877 0.975
(0.647, 0.886) (0.52, 0.927) (0.718, 1.126) (0.713, 1.041 (0.750, 1.200)
35-9 0.635 0.518 0.790 0.702 0.586
(0.482, 0.762) (0.32, 0.716) (0.554, 1.027) (0.553, 0.851) (0.403, 0.770)
40-4 0.551 0.577 0.686 0.551 0.807
(0.409, 0.795) (0.324, 0.83) (0.375, 0.996) (0.376, 0.725) (0.559, 1.055)
45-9 0.356 0.339 0.177 0.323 0.300
(0.159, 0.544) (0.085, 0.594) (-0.095, 0.450) (0.170, 0.476) (0.091, 0.509)
50-4 0.295 0.304 – – 0.112
(0.095, 0.679) (-0.021, 0.63) – – (-0.083, 0.307)
55-9 0.246 0.395 – – 0.176
(0.087, 0.627) (0.027, 0.764) – – (0.013, 0.338)
analysis are responsible for the discrepancies between the two sets of results. For example, it is possible to
evaluate the binomial distribution for non-integer counts using the binomial function in Microsoft Excel, but
this is not possible when using the binomial function in R. Therefore, we feel it is inappropriate to compare the
log likelihood obtained via our estimation procedure to that of Heuveline. When we use our software and code
to evaluate the log likelihood at Heuveline’s ML estimates, the value is much lower than the log likelihood at
our ML estimates (-654.02 vs -579.58).
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Table 6: (Continued)
Heuveline Thomas & Clark
Original Original New Data All
Parameters Data Data Gamma Constant Data
Male Age-Speciﬁc
Relative Incidence Ratio
15-9 0.059 0.11 0.262 0.167 0.274
(0.024, 0.109) (0.065, 0.155) (0.214, 0.310) (0.138, 0.196) (0.226, 0.323)
20-4 0.583 0.508 0.427 0.329 0.466
(0.483, 0.684) (0.387, 0.63) (0.333, 0.521) (0.272, 0.385) (0.376, 0.556)
25-9 1.149 1.024 1.171 0.883 1.216
(0.986, 1.285) (0.807, 1.242) (0.980, 1.362) (0.764, 1.002) (1.033, 1.400)
30-4 0.963 0.998 1.387 1.201 1.383
(0.773, 1.130) (0.743, 1.252) (1.128, 1.647) (1.032, 1.370) (1.150, 1.617)
35-9 0.759 0.723 0.849 0.894 0.708
(0.573, 0.944) (0.452, 0.993) (0.533, 1.165) (0.696, 1.091) (0.485, 0.931)
40-4 0.769 0.759 0.818 0.835 1.088
(0.554, 1.007) (0.442, 1.077) (0.413, 1.223) (0.609, 1.062 (0.790, 1.385)
45-9 0.622 0.628 0.444 0.335 0.379
(0.409, 0.879) (0.297, 0.959) (0.145, 0.743) (0.137, 0.534) (0.130, 0.628)
50-4 0.417 0.288 0.519 0.458 0.483
(0.120, 0.773) (-0.093, 0.668) (0.145, 0.743) (0.249, 0.668) (0.194, 0.772)
55-9 0.168 0.219 0.526 0.466 0.189
(0.001, 0.445) (-0.114, 0.552) (0.081, 0.971) (0.189, 0.743) (-0.084, 0.462)
Log Likelihood -567 -580 -1799 -2121 -3444
Note: There are two sets of estimates based on the new data sources: one using the gamma trend for HIV
incidence, and another using a constant trend. The 95% conﬁdence intervals for each parameter are shown
in parentheses.
There are two sets of results, presented in Table 6, from our analysis of the new data
sources. This new data compilation does not contain enough information to calculate
the CCMPP parameters related to fertility or the relative incidence ratios for women in
the 50-4 and 55-9 year age groups. The set of estimates shown under the column heading
“Gamma”arebasedonthesamespeciﬁcationoftheHIV-enabledCCMPPusedtoanalyze
the original data. More speciﬁcally, the trend in HIV incidence is derived from the gamma
distribution (see Equation 16 and Table 1) with a peak level of incidence occurring 12
years into the epidemic and a decline thereafter. The second set of results estimated with
the new data sources is based on a constant rate in HIV incidence over time. These two
sets of estimates are very similar to each other, and the estimated age pattern of HIV
infection is consistent with the results obtained using the original data. The age proﬁle
for men, however, is different when the new data are used, regardless of the assumed
underlying trend in HIV incidence. Although the uncertainty around the point estimates
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makes it difﬁcult to precisely identify the age at which the risk of infection peaks, the
results suggest that men aged 30-34 experience the highest risk of infection. This is
sligthly older than the peak age of infection for men estimated from the original data,
the 25-29 year age group. This ﬁnding is particularly interesting given that the new data
compilation consists of observations that are closer to the present, which may suggest that
the age pattern of HIV incidence changes as the epidemic matures. Shafer et al. (2008)
report a similar ﬁnding from a cohort study in Uganda. The results from the new data
also suggest that the model based on the trend in HIV incidence derived from the gamma
distributionﬁtsthedatabetterthanamodelwithaconstanttrendinHIVincidence, asseen
by comparing the log likelihoods for each model (gamma: -1790, vs. constant: -2121).
Although the gamma trend ﬁts these new data relatively well, the CCMPP estimates for
more complicated models (presented in the next section) are much more unstable than
those obtained from the speciﬁcation of a constant incidence trend. Thus, a constant
incidence trend is assumed for extensions of the CCMPP, and the corresponding results
for the original model are presented here for the purpose of comparison.
The ﬁnal set of estimates presented in Table 6 are the result of using all of the data
to estimate the parameters. The estimate of the vertical transmission rate is virtually
identical to the previous estimates, but the results concerning the other parameters related
to fertility are noticeably different. When all the data are used in the analysis the point
estimate of the early-selection fertility coefﬁcient is higher, and the fertility impairment
parameters are 0.749 (0-4 years), 1 (5-9), and 0.433 (10+) which is different from the
monotonic decline we expect to see. Turning now to the relative incidence ratios, we
see a different pattern of infection by age than what is estimated using solely the original
data, or the new data only. When all the data are used, the risk of infection among women
rises until peaking at ages 20-24 years, then declines before increasing again among those
aged 40-44 years, and ﬁnally reaching much lower levels at the oldest ages. The age
pattern for men is similar in that the risk of infection rises after the peak years of infection
at ages 30-34. Similar patterns of HIV incidence have been observed in other African
populations (˙ Zaba et al. 2008), and a much more muted version is estimated using the
original data. Perhaps the subsequent rise in the risk of infection after the peak is simply
due to sampling variability or heterogeneity across the data compilations, but there may
be behavioral patterns associated with union instability that can generate these results
(˙ Zaba et al. 2008).
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4.1 Modeling survival for the infected population
One modeling assumption in the HIV-enabled CCMPP is that the lower survival rates
associated with HIV/AIDS (captured by the parameters sa;d for d ¸ 2) are known. While
it is possible to specify a realistic survival schedule for the infected population, a more
appealing extension of the model is to estimate the additional force of mortality associated
with HIV/AIDS. This approach also seems reasonable since there are more data available
on the survival experiences of HIV+ cohorts that are not included in the original data
compilation used by Heuveline (2003). Recall that the projected counts in the CCMPP
are calculated as
na+1;1;t+1 = na;1;t sa;1;t (1 ¡ ia;t)
na+1;2;t+1 = na;1;t sa;1;t ia;t sa;2
na+1;d;t+1 = na;d¡1;t sa;1;t sa;d for d > 2;
with sa;d¸2 capturing the reduced survival prospects associated with HIV/AIDS for each
duration group. Instead of treating these model inputs as ﬁxed, we can estimate the sa;d¸2
in various ways. A parsimonious approach is to ignore the dependence on age at infec-
tion15 and assume that survival is only a function of the duration of infection, which can
be expressed as sd for d ¸ 2 (dropping the subscript for age group). These four new
model inputs (one for each HIV+ duration group) can be estimated along with the other
CCMPP parameters estimated in the previous section. The results for this model are pre-
sented in Table 7 along with estimates from the model with ﬁxed survival, for the purpose
of comparison. As with the previous results, estimates are shown for results obtained
from using the original data compiled by Heuveline, the new data with the constant trend
in HIV incidence, and all of the data sources combined.
15 Heuveline (2003) speciﬁed the model so that expected survival time declines as the age at infection increases
(among adults).
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Table 7: Maximum likelihood estimates for the modiﬁed CCMPP that
includes duration-speciﬁc survivorship coefﬁcients for the
infected population
Parameters Original Data Fixed Surv. Original Data New Data All Data
Female Age-Speciﬁc
Relative Incidence Ratio
15-9 0.585 0.529 0.621 0.837
(0.471, 0.698) (0.423, 0.635) (0.537, 0.705) (0.724, 0.950)
20-4 1.297 1.28 1.277 1.553
(1.04, 1.553) (1.039, 1.521) (1.092, 1.461) (1.316, 1.791)
25-9 (referent) 1.000 1.000 1.000 1.000
– – – –
30-4 0.724 0.703 0.930 0.891
(0.52, 0.927) (0.513, 0.893) (0.736, 1.123) (0.688, 1.093)
35-9 0.518 0.498 0.836 0.434
(0.32, 0.716) (0.308, 0.688) (0.654, 1.019) (0.266, 0.602)
40-4 0.577 0.543 0.534 0.822
(0.324, 0.83) (0.319, 0.766) (0.343, 0.725) (0.595, 1.048)
45-9 0.339 0.304 0.259 0.191
(0.085, 0.594) (0.076, 0.531) (0.061, 0.457) (-0.009, 0.392)
50-4 0.304 0.246 – 0.169
(-0.021, 0.63) (-0.052, 0.544) – (-0.058, 0.395)
55-9 0.395 0.331 – 0.171
(0.027, 0.764) (0.011, 0.65) – (-0.005, 0.346)
Male Age-Speciﬁc
Relative Incidence Ratio
15-9 0.11 0.1 0.183 0.263
(0.065, 0.155) (0.059, 0.141) (0.147, 0.219) (0.216, 0.310)
20-4 0.508 0.479 0.354 0.493
(0.387, 0.63) (0.367, 0.59) (0.285, 0.422) (0.403, 0.583)
25-9 1.024 0.982 0.942 1.219
(0.807, 1.242) (0.782, 1.182) (0.797, 1.086) (1.046, 1.393)
30-4 0.998 0.974 1.277 1.283
(0.743, 1.252) (0.739, 1.209) (1.075, 1.478) (1.062, 1.504)
35-9 0.723 0.71 0.866 0.721
(0.452, 0.993) (0.461, 0.959) (0.642, 1.090) (0.510, 0.932)
40-4 0.759 0.705 0.842 0.726
(0.442, 1.077) (0.425, 0.986) (0.575, 1.110) (0.481, 0.971)
45-9 0.628 0.564 0.442 0.477
(0.297, 0.959) (0.27, 0.858) (0.189, 0.695) (0.238, 0.717)
50-4 0.288 0.197 0.360 0.204
(-0.093, 0.668) (-0.152, 0.545) (0.075, 0.646) (-0.064, 0.472)
55-9 0.219 0.183 0.331 0.108
(-0.114, 0.552) (-0.105, 0.471) (-0.013, 0.676) (-0.085, 0.301)
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Table 7: (Continued)
Parameters Original Data Fixed Surv. Original Data New Data All Data
Duration-Speciﬁc HIV
Survivorship Coefﬁcients
0-4 years – 1 1.000 1.000
– (0.843, 1.157) (0.800, 1.200) (0.922, 1.078)
5-9 years – 0.602 0.821 0.658
– (0.557, 0.647) (0.754, 0.889) (0.602, 0.714)
10-4 years – 0.609 0.726 0.611
– (0.29, 0.929) (0.611, 0.840) (0.451, 0.771)
15 years and above – 1 0.147 0.968
– (-2.887, 4.887) (0.043, 0.252) (0.612, 1.325)
Log Likelihood -580 -569 -2030 -3214
Notes: Results are presented for analyses obtained by using the original data compiled by Heuveline (2003), new
data, and all of the data sources combined. The 95% conﬁdence intervals for each parameter are shown in
parentheses. Survival for the infected populations is equal to the product of these duration-speciﬁc coefﬁ-
cients and the appropriate survivorship ratio applied to the uninfected population; see text for more details.
(CCMPP parameters related to fertility are not shown.)
First, focus on the results obtained using the original data compiled by Heuveline
(2003). Estimates of the CCMPP parameters related to fertility are very similar to the
corresponding results from the model with ﬁxed survival (results not shown), and the
same is true for the age pattern of HIV incidence for both men and women. Among the
ﬁrst HIV duration group, there is no signiﬁcant difference between the survival prospects
of the infected and uninfected populations, but survival declines by a factor of 0.6 (relative
to the uninfected population in the same age group) for the next two HIV duration groups,
5 to 9 and 10 to 15 years. The survivorship coefﬁcient for the longest HIV duration group
is estimated to be 1, which suggests no difference in the survival prospects between those
infected for 15 or more years and the uninfected population (in the corresponding age
group). This result is obviously nonsense, but the large amount of uncertainty around
the point estimate drastically reduces the amount of weight that should be placed on this
ﬁnding. A ﬁnal note is that the ML estimates for the CCMPP modiﬁed to estimate the
survival of the infected population have a larger log likelihood than the result for the
original model. This result is expected, since the former model includes four additional
parameters, but it is encouraging to see the extension of the model gaining some traction.
Turning now to the results obtained using the new data, we see results that are qual-
itatively similar to those obtained from the model with a ﬁxed survival schedule for the
infected population. Among women, the risk of infection peaks among those aged 20-24,
and declines monotonically into the older ages. Again, men in the 30-34 year age group
are estimated to experience the highest risk of infection, which appears to be slightly older
than the results obtained using the original data, but the uncertainty around the point esti-
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mates make it difﬁcult to draw any strong conclusions. The estimated survival parameters
show a decline in the prospects of survival as the duration of infection increases, with a
fairly large drop for the longest duration group. These additional parameters increase the
log likelihood from -2,121 to -2,030, suggesting an improvement in the model ﬁt to the
data.
The ﬁnal set of results shown in Table 7 pertains to estimating the survivorship coef-
ﬁcients of the CCMPP model with all of the data sources combined. The age patterns of
HIV incidence are somewhat similar to the estimates from the model with a ﬁxed survival
schedule for the infected population. Among women, the risk of infection rises and then
peaks at the 20-4 age group, with a subsequent increase among those aged 40-44. The
age pattern for men is characterized by a peak in the risk of infection at ages 30-4, as seen
before, but when survival is estimated, the subsequent rise in HIV incidence after the peak
is smoothed out. The survival estimates suggest no difference in the survival prospects
between the HIV+ population infected for less than ﬁve years and the uninfected pop-
ulation in the same age group. Survival decreases by a factor of around 0.66 for those
infected for 5 to 9 years, but the point estimates do not show a continued decline for the
longer duration groups and there is too much uncertainty around the estimates to detect
any differences for these groups. Finally, we ﬁnd that adding the survivorship coefﬁcients
to the estimation procedure increases the log likelihood at the ML estimates from -3,444
to -3,214, again suggesting that the model ﬁt is improved when the survival schedules of
the infected population are estimated.
Given the large number of parameters already included in the HIV-enabled CCMPP,
the parsimonious model extension explored above is a reasonable ﬁrst step. Previous re-
search, however, suggests that the age at infection is a critical determinant of survival post
infection (UNAIDS Reference Group on Estimates, Modelling and Projections 2002).
One possible strategy is to take a parametric approach, which is useful here because it al-
lows for more complicated patterns of mortality to be speciﬁed with only a few additional
parameters. We follow the lead of ˙ Zaba et al. (2007) and use a Weibull distribution to
model the change in the survival prospects of the infected population, so that it depends
on age at infection. Let the mortality rate for those infected in age group a after t years of
HIV infection be
m(a;t) = ®at®a¡1e¡¯
where ®a and ¯ are the Weibull parameters to be estimated. The mortality rates from
this model increase with higher values of the ®a parameter, whereas mortality decreases
with higher values of the ¯ parameter. To convert the mortality rate into the survivorship
ratio needed for the CCMPP, exponentiate the negative of the cumulative hazard function
over the appropriate range as follows













In the interest of parsimony, we combine several age groups and estimate two ®a pa-
rameters for those aged 15-29 and 30-59 years, as well as a single ¯ parameter that is
shared across all groups. Estimates of the CCMPP parameters using this speciﬁcation of
survival for the infected population are shown in Table 8. Results are only shown for both
the original data and the new data, with the latter obtained from assuming a constant level
of HIV incidence over time. The corresponding results obtained by combining all of the
data sources are not shown because of the lack of stability in the parameter estimates.
Table 8: Maximum likelihood estimates for the modiﬁed CCMPP
with a Weibull model used to specify the survival for the
infected population (see text for more details)
Parameters Original Data Fixed Surv. Original Data New Data
Female Age-Speciﬁc Relative Incidence Ratio
15-9 0.585 0.544 0.653
(0.471, 0.698) (0.435, 0.654) (0.573, 0.733)
20-4 1.297 1.278 1.261
(1.04, 1.553) (1.031, 1.525) (1.080, 1.443)
25-9 (referent) 1.000 1.000 1.000
– – –
30-4 0.724 0.742 0.913
(0.52, 0.927) (0.542, 0.943) (0.707, 1.119)
35-9 0.518 0.561 0.751
(0.32, 0.716) (0.358, 0.764) (0.569, 0.933)
40-4 0.577 0.618 0.878
(0.324, 0.83) (0.370, 0.866) (0.628, 1.128)
45-9 0.339 0.320 0.288
(0.085, 0.594) (0.074, 0.566) (0.062, 0.514)
50-4 0.304 0.293 –
(-0.021, 0.63) (-0.033, 0.620) –
55-9 0.395 0.363 –
(0.027, 0.764) (0.016, 0.710) –
Male Age-Speciﬁc Relative Incidence Ratio
15-9 0.11 0.104 0.195
(0.065, 0.155) (0.060, 0.147) (0.159, 0.232)
20-4 0.508 0.486 0.346
(0.387, 0.63) (0.371, 0.602) (0.277, 0.416)
25-9 1.024 0.982 0.959
(0.807, 1.242) (0.777, 1.186) (0.812, 1.106)
30-4 0.998 1.009 1.257
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Table 8: (Continued)
Parameters Original Data Fixed Surv. Original Data New Data
Male Age-Speciﬁc Relative Incidence Ratio
(0.743, 1.252) (0.758, 1.260) (1.044, 1.469)
35-9 0.723 0.763 0.779
(0.452, 0.993) (0.489, 1.037) (0.554, 1.005)
40-4 0.759 0.806 1.334
(0.442, 1.077) (0.495, 1.117) (0.991, 1.677)
45-9 0.628 0.607 0.343
(0.297, 0.959) (0.282, 0.931) (0.051, 0.635)
50-4 0.288 0.262 0.557
(-0.093, 0.668) (-0.121, 0.645) (0.238, 0.867)
55-9 0.219 0.197 0.410
(-0.114, 0.552) (-0.113, 0.507) (0.048, 0.771)
Weibull Parameter ®a
15-29 years – 2.007 4.612
– (1.214, 2.800) (3.457, 5.767)
30-59 years – 2.118 4.951
– (1.332, 2.904) (3.766, 6.135)
Weibull Parameter ¯ – 0.557 1.340
– (0.372, 0.742) (1.019, 1.661)
Log Likelihood -580 -577 -2101
Notes: Results are presented for analyses obtained by using the original data compiled by Heuveline (2003) and the
new data sources. The 95% conﬁdence intervals for each parameter are shown in parentheses. (CCMPP
parameters related to fertility are not shown.
Focusing ﬁrst on the results obtained using the original data, we see that the estimates
from the CCMPP with survival for the infected population based on the Weibull are very
similar to the estimates based on the CCMPP with a ﬁxed survival schedule for the in-
fected population. The estimates of the Weibull parameters suggest, as expected, that the
survival prospects are poorer for those infected in the 30-59 age category relative to the
15-29 category. The high level of uncertainty around these point estimates does not allow
us to identify differences between the ®a parameters, and thus an even simpler model
that ignores age at infection may sufﬁce. In the corresponding model presented in Ta-
ble 7, survival does not depend on age at infection and the log likelihood is -569, which
compares favorably against the Weibull model shown in Table 8, with a log
likelihood of -579.
Estimating the survival of the infected population via our Weibull speciﬁcation with
the new data results in age patterns of HIV incidence that are different from those pre-
sented earlier, particularly among men. Recall that in the previous results estimated from
the new data risk of infection for men increased until peaking at ages 30-34, and then
declined with age. For our Weibull speciﬁcation, there appears to be a post-peak increase
in HIV incidence among men aged 40-44. The width of the conﬁdence intervals casts
uncertainty over this ﬁnding, but it does seem clear that the estimated age pattern of HIV
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incidence is sensitive to the survival schedule used for the infected population. A similar
pattern is observed for women, with a peak in the risk of incidence at ages 20-24 and a
subsequent increase among those aged 40-44, but the magnitudes of these differences are
smaller than those observed among men. The survival estimates suggest that the risk of
mortality is greater when HIV infection occurs after age 29, but there is too little power in
these data to determine if this is a real difference. A ﬁnal point is that when the new data
are analyzed, the Weibull speciﬁcation has a smaller log likelihood than the speciﬁcation
which ignores age at infection (-2101 vs. -2030).
Toassistwiththeinterpretationofoursurvivalresults, weusedtheestimatedsampling
distribution of the model parameters to generate 300 projections of the age-speciﬁc mor-
tality rates for Uganda, as shown by the grey lines in the plots in Figure 2. The mortality
rates shown in this ﬁgure correspond to the results estimated using the new data for time
periods that are 5, 15, and 30 years into the HIV epidemic. Projections from the model
based on directly estimating the survivorship coefﬁcients are shown in the ﬁrst row, and
the projections from the Weibull model are presented in the second row. For comparitive
purposes, ﬁtted values from the model estimated by ˙ Zaba et al. (2007) are also included
in each plot. ˙ Zaba et al. (2007) note that the mortality rates of the infected population will
change as the epidemic matures and the average duration of infection increases. Their
theoretical and empirical investigation points to two characteristics that help identify the
appropriate age pattern of mortality (among the infected population) for a given stage of
the epidemic. The ﬁrst characteristic is a decline in HIV prevalence, indicating higher
mortality, and the second is the ratio of HIV prevalence among the dead to HIV preva-
lence among the living, which mirrors the infected mortality rate at a lag of roughly three
years. ˙ Zaba et al. (2007) include these indicators as covariates in a Weibull model to esti-
mate the mortality rates of the infected population using data from various cohort studies
in sub-Saharan Africa. Their model produces four age patterns of mortality for infected
individuals: HIV prevalence is not declining and the ratio of dead to living HIV preva-
lence is less than 4 (denoted as ˙ Zaba 1); HIV prevalence is declining and the ratio of dead
to living HIV prevalence is less than 4 (˙ Zaba 2); HIV prevalence is not declining and the
ratio of dead to living HIV prevalence is greater than 4 (˙ Zaba 3); and HIV prevalence is
declining and the ratio of dead to living HIV prevalence is greater than 4 (˙ Zaba 4). These
four patterns are included in the plots in Figure 2.
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Figure 2: Estimated mortality rates for Uganda based on CCMPP
parameter estimates for survivorship model (method 1), the
Weibull model (method 2), and model age-speciﬁc mortality
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Note: See text for more details. ˙ Zaba1 – HIV prevalence is not declining, ratio of HIV prevalence among the dead
to prevalence among the living < 4; ˙ Zaba2 – HIV prevalence is declining, ratio < 4; ˙ Zaba3 – HIV
prevalence is not declining, ratio > 4; ˙ Zaba4 – HIV prevalence is declining, ratio > 4.
Both of the CCMPP speciﬁcations produce the same general mortalty patterns by
age, as seen in Figure 2. As the epidemic matures and the average duration of infection
increases the mortality rates at the older ages increase. There is very little change over
time at the younger ages because these groups primarily consist of recent infections (due
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to the close proximity between the current age and the age at which risk exposure, via
sexual intercourse, begins). Our estimates suggest that the mortality rates among the
infected population continue to increase over the ﬁrst three decades of the epidemic. For
theWeibullspeciﬁcationoftheCCMP,thedualpeaksintheestimatedagepatternsofHIV
incidence, particularly among men, are reﬂected in the age-speciﬁc mortality rates among
those aged 35-39 and 50-54. The levels of mortality associated with our estimates are
generally lower than the age patterns estimated by ˙ Zaba et al. (2007). This descrepancy
is most likely attributable to the differences in the sources of data used in each analysis.
The vast majority of the data used to generate our results consists of observations on
HIV prevelance, whereas ˙ Zaba et al. (2007) conduct a survival analysis which primarily
uses observations on deaths and person-years at risk. Given that the approach of ˙ Zaba
et al. (2007) is more direct, this comparison suggests that we may be underestimating
the force of mortality experienced by infected individuals.16 Some studies have reported
mortality rates among the infected population that are fairly similar to our estimates. For
example, a study of HIV-positive South African miners reports a crude mortality rate
(from natural causes) of .0271 during the 1990s (Murray et al. 2007), and point estimates
of age-speciﬁc mortality rates from a cohort study in Zimbabwe are less than .07 (Smith
et al. 2007). Data from Kwazulu-Natal, South Africa, collected during the period from
2004 to 2006, suggest that mortality is slightly higher among the infected population, with
average annual mortality rates of .025, .060, .076, and .0100 among those 15-24, 25-34,
35-44, and 45-54 years of age (Nyirenda et al. 2007). Estimates of the median survival
time from HIV infection to death include 8.7 years in Rakai, Uganda (Lutalo et al. 2007),
9.0 years in Masaka, Uganda (Van der Paal et al. 2007), and 11.9 years in Kigali Rwanda
(Peters et al. 2007), which also suggest that our mortality estimates, and the associated
median survival times of roughly 14 (method 1) and 16 (method 2) years, are understating
the probability of dying among the infected population.
As a further check on the validity of our parameter estimates for the CCMPP with esti-
mated survival for the infected population, we compare our estimated age patterns of HIV
incidence to those of ˙ Zaba et al. (2008). Again, we use the estimated sampling distribu-
tion of the model parameters to generate 300 projections of the annual age-speciﬁc HIV
incidence rates for women and men in Rakai, Uganda; Kisesa, Tanzania; and Manica-
land, Zimbabwe. Figure 3 shows our estimated age patterns (grey lines) along with those
esimated by ˙ Zaba et al. (2008), who ﬁt a cubic splines model to survival data on HIV inci-
dence for these same populations. Our estimates correspond to the CCMPP speciﬁcation
in which we directly estimate the survivorship coefﬁcients (see Table 7).
16 Another possible reason that our results are lower is that the rates we are using for background mortality, i.e.
the force of mortality in the absence of HIV/AIDS, are too high, since the lowering background mortality would
require an increase in mortality among the infected to produce the same population projections.
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Figure 3: A comparison of age patterns of annual HIV incidence rates in
East Africa between CCMPP estimates (grey lines) and those esti-
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There are two types of differences between the age patterns shown in Figure 3. The
ﬁrst refers to the overall level of the age pattern, and the second consists of differences
in the shape of the pattern. Our estimates for both women and men tend to be higher for
Rakai and Manicaland, but lower in Kisesa. Relative to our results, the estimates of ˙ Zaba
etal.(2008)peakatanolderageamongwomen, whiletheshapeoftheagepatternsamong
men is fairly similar, with the possible exception that our results are lower at the youngest
ages. Before addressing the possible explanations for these differences, it is important to
note that none of the uncertainty around the estimates of ˙ Zaba et al. (2008) is presented
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in these plots, which may exagerate the magnitude of the differences. One possible cause
of the differences is that very little data are used to estimate the size of the epidemic in
Rakai and Manicaland. For each of these sites, only one data set is used to estimate the
CCMPP parameter (see Equation 4), whereas three data sets contribute information to the
size of the epidemic in Kisesa and the resulting level differences between the two models
are smaller.
The discrepancies observed in Figure 3 may also be due to misspeciﬁcations in the
CCMPP. For example, our results are based on the assumption of a ﬂat trend in HIV
incidence, which may be unrealistic and erroneously inﬂuence the estimated age pattern.
Heuveline (2003) found only minor differences in the age patterns of HIV incidence based
ontheCCMPPwithdifferenttrendsinincidence. Similarly, weﬁndsimilarpatternsbased
on different trends (see Table 7). While these ﬁndings suggest that the age proﬁle is fairly
insensitive to the assumed trend in HIV incidence for the CCMPP, the question is still
open, given that only a small number of different trends have been explored with this
model. Another problem may be that we are assuming that the shape of the age pattern
of HIV incidence stays the same over the course of the epidemic. Basic demographic
changes, as well as differential behavioral responses by age could generate these dynam-
ics in the risk of infection (˙ Zaba et al. 2008). A ﬁnal point is that our age patterns are
estimated primarily using data on HIV prevalence, which depends on both incidence and
survival. Our earlier ﬁndings, shown in Figure 2, suggest that we may be underestimat-
ing the mortality rates of the infected population. If the CCMPP parameters governing
the survival of the infected population are decreased to reﬂect higher mortality, then the
incidence parameters would also need to be increased to generate the same levels of HIV
prevalence. Since our ﬁndings suggest that the bias in our mortality estimates varies sys-
tematically by age, with larger differences at older ages, correcting this bias would most
likely change the estimated age pattern of HIV incidence. As stated earlier, future studies
on the survival of the infected population should publish their results by age so that this
information can be utilized by age-speciﬁc models such as CCMPP.
4.2 An application to a rural South African population
The estimates presented above are obtained using data from countries located in East
Africa. This gives rise to the question of regional variation within sub-Saharan Africa.
We explore this question with an application of CCMPP to a population living in a rural
area of the KwaZulu-Natal province of South Africa. Data from this population published
by Welz et al. (2007) include age-speciﬁc HIV prevalence for the following age groups:
15-19, ..., 45-49 for women; and 15-19, ..., 50-54 for men.17 The data are further
17 We also attempted to use the mortality rates of the infected population published by Nyirenda et al. (2007),
but we were unable to obtain maximum likelihood estimates for which we could estimate a covariance matrix.
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classiﬁed by resident status, with non-residents being individuals whose main residence is
elsewhere but who maintain regular contact with the surveyed household through periodic
visits. Prevalence is generally much higher among non-residents, which is consistent
with the ﬁnding that migrants are at a higher risk of becoming infected. We model this
difference by estimating CCMPP with separate parameters for the level of the epidemic
for residents and non-residents. The results from this model are presented in Table 9 under
the column labeled ’full model’. We also report estimates for a reduced model, for which
incidence is constrained to be equal across certain age groups: for women 30-49 and for
men 25-34 and 35-54.
Relative to males, incidence among females is much higher in the youngest age group.
Incidence peaks among women between the ages of 20 and 29 while the peak for men
occurs during the late twenties and early thirties. There is a relatively large drop in relative
incidence after the peak for women. Recall that women between the ages of 25 and 29
serve as the reference group, with their relative incidence ﬁxed at a value of 1. Relative
incidence for women in the next oldest age group has a 95% conﬁdence interval of (-0.11,
0.51). There is a similar ﬁnding for men, but it is much less pronounced. With respect
to the two resident groups, residents and non-residents, the estimates do not indicate a
difference in the level of the epidemic.
The amount of uncertainty around the estimates in the full model motivated the esti-
mationofamoreparsimoniousmodel. Notehowtheconﬁdenceintervalsbecomeincreas-
ingly wider with age.18 With relatively few data, we are unable to identify differences
between the point estimates for relative incidence after the peak. The ‘reduced model’
column in Table 9 displays estimates for a simpler model that collapses all post-peak age
groups for women and includes only two parameters for relative incidence among men
older than 34. The results show an age pattern similar to that seen for the full model, and
there is more precision around the estimates for this reduced model. We again ﬁnd little
support for the hypothesis that the HIV epidemic is at a higher level among non-residents,
but in both cases the estimates of epidemic scale are much higher than those from the sites
in East Africa.
18 It should also be pointed out that two of the conﬁdence intervals include negative values that are problematic,
since these parameters are naturally bounded at zero.
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Table 9: CCMPP parameter estimates and 95% conﬁdence intervals using
data from KwaZulu-Natal, South Africa
Parameters Full Model Reduced Model
Female Relative Incidence Ratio
15-9 0.26 0.27
(0.2, 0.33) (0.22, 0.32)
20-4 0.63 0.64











Male Relative Incidence Ratio
15-19 0.02 0.02
(0.01, 0.03) (0.01, 0.03)
20-24 0.2 0.21
(0.14, 0.27) (0.16, 0.27)
25-29 0.69 0:65b













(1.41, 2.13) (1.5, 1.95)
Non-Residents 2.45 2.39
(1.86, 3.03) (1.95, 2.83)
Notes:
a This is the parameter estimate for women between the ages of 30-49.
b This is the parameter estimate for men between the ages of 25-34.
c This is the parameter estimate for men between the ages of 35-54.
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An interesting comparison between the full and reduced models is made by project-
ing prevalence and combining the age groups to obtain an estimate of adult prevalence
which can then be compared to observed prevalence.19 To get a sense of the uncertainty
around these estimates, we appeal to asymptotics and sampled CCMPP inputs from a
multivariate normal distribution, with the mean and covariance matrix taken from the ML
estimates. For each set of inputs in the sample we run CCMPP and the corresponding out-
puts are used as a predictive distribution. The 0.025 and 0.975 quantiles of this predictive
distribution are reported together as the 95% predictive interval (95% PI).
Welz et al. (2007) report that 21.5% of all adult residents aged 15-49 are HIV+ (preva-
lence for non-residents is not given). Using the ML estimates as the model inputs gives
a predicted prevalence of 25.9% (95% PI: 24.8 – 26.9%) which is much too narrow. Fig-
ures 4 & 5 show the projected prevalence for women and men, respectively. There is
a pair of boxplots for each ﬁve-year increment over time up to 2003, the year of data
collection, and ten years into the future. The boxplot on the left (right) refers to the full
(reduced) model. Among women the projections match the observed prevalence of adults
much better for non-residents than for residents. Predicted prevalence is too high for
adult female residents. As seen in Panel (a) of Figure 4 the predictive interval for the full
model barely includes the observed prevalence in 2003, while the corresponding interval
for the reduced model is too narrow. Among non-resident women (Panel (b)), for whom
prevalence is much higher, the predictive intervals for both models cover the observed
prevalence in 2003. Finally the predictive intervals tend to be larger for non-residents in
both the full and reduced models.
The results for men are shown in Figure 5, with residents presented in Panel (a) and
non-residents in Panel (b). The ﬁndings are similar to those of women, in that the pro-
jections tend to be too high for residents and too low for non-residents. The ﬁt appears
to be slightly worse among men in that the predictive intervals appear to be too narrow.
As found with women, the reduced model provides very similar projections to the more
complicated model.
19 This partially serves as a check for the age distribution of the initial population and the choice of vital rates.
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Note: The horizontal and vertical dashed lines indicate the prevalence and year, respectively, from the observed
data.
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Note: The horizontal and vertical dashed lines indicate the prevalence and year, respectively, from the observed
data.
Given the high level of observed prevalence in KwaZulu-Natal it is interesting to ex-
plore the long term implications of the estimated CCMPP parameters for the population.
The eigenvector corresponding to the largest real eigenvalue of the Leslie matrix is the
stable age distribution (Keyﬁtz and Caswell 2005). The population pyramid for the stable
equivalent population is presented in Figure 6 with men on the left and women on the
right. The white horizontal bars represents the proportion of the total population in an
age group and the black section of each bar indicates the proportion of the population in
that age group that is HIV+. The dots at the end of each bar indicate the 95% conﬁdence
intervals around the proportion represented by the bar – they are very narrow.
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In the stable population HIV prevalence resembles the age proﬁle for incidence. There
is an earlier peak for women occurring among women between the ages of 25 and 29.
Among men the peak is at the next older age group, and HIV prevalence is generally
lowerrelativetowomen. Prevalenceissohighamongwomen(25%)thatthefemalestable
population is actually shrinking. In contrast the male stable population (prevalence 17%)
is growing slowly – which hints at possible pressure on the sex ratio of this population.
Figure 6: Projected population pyramid for the stable equivalent population
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HIV−
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Note: The white bars indicate the proportion of the population in each age group (HIV– and HIV+ combined),
while the black bars indicate the proportion of the total population who are HIV+ in each age group. 95%
conﬁdence intervals are depicted by the dots.
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5. Discussion
In this article we extend the work of Heuveline (2003) by developing a Leslie matrix
representation of his HIV-enabled CCMPP, updating the data sources used to estimate
the parameters, estimating the survival of the infected population, and by providing new
estimates for a rural population living in the KwaZulu-Natal province of South Africa.
Our ﬁndings based on the original data are broadly similar to Heuveline’s, in that for
women incidence peaks between the ages of 20 and 24 and for men between the ages of
25 and 34. However, we also ﬁnd that the estimated age patterns are sensitive to the data
used to ﬁt the CCMPP. When “newer” data, collected more recently than those compiled
by Heuveline (2003), are analyzed the peak age of HIV incidence among men is more
narrowly peaked in the 30 to 34 year age range. Among men, the age pattern estimated
from the South African data has the same shape, but the risk of HIV incidence peaks
among women in the 25-29 age group.
One of the beneﬁts of a modeling approach to studying HIV/AIDS epidemics is that
data on prevalence, incidence, and survival can be jointly utilized to estimate consistent
age patterns for each outcome (Ghys et al. 2006). Our results, based on generalizing the
HIV-enabled CCMPP to estimate mortality associated with HIV, suggest that a simple
model of survival that is independent of the age at infection can perform quite well rel-
ative to the CCMPP based on a ﬁxed survival schedule. It is possible to specify more
complicated models for the survival of the HIV-positive groups, but our attempt at this
has added very little to the ﬁt of the model (as indicated by changes in the log likelihood
evaluated at the ML estimates). A comparison of our estimates to those from a differ-
ent study, however, suggests that we may be underestimating the mortality rates for the
infected population. This potential bias is troubling since estimates of HIV incidence de-
pend on the pattern of mortality among the infected population, as noted in previous work
on devising methods for estimating incidence by age (e.g. Hallett et al. 2008).
The shortcomings in our analysis have implications for modeling efforts and pop-
ulation projections more generally. Perhaps the most likely cause of the discrepancies
between our estimates and those of other studies is that we are not using enough informa-
tion to estimate the parameters, particularly with respect to the survival experiences of the
infected population. There are numerous high quality HIV cohort studies (e.g. Van der
Paal et al. 2007; Lutalo et al. 2007; Smith et al. 2007; Peters et al. 2007; Isingo et al. 2007;
Murray et al. 2007), and we encourage future work with these data to stratify their results
by age (with reports of the number of events and person-years at risk when appropriate) so
that age-speciﬁc models such as CCMPP can take advantage of these valuable resources.
This will be very helpful in future efforts aimed at modeling the dynamics associated with
the expanding availability and coverage of antiretroviral therapies.
Another implication of our work is highlighted by the potential misspeciﬁcations of
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the CCMPP, with the most problematic being the assumed trend in HIV incidence. The
empirical record suggests that both mortality and fertility depend on the duration of HIV
infection (Porter and ˙ Zaba 2004; ˙ Zaba et al. 2007; Lee et al. 2000; Desgrées du Loû
et al. 1999; Sedgh et al. 2005; Nguyen et al. 2006; Hunter et al. 2003). As an epidemic
matures, the distribution of duration times will change, and thus the impact of HIV at
the population level will also change over time. Modeling this dynamic depends heavily
on the trend in HIV incidence, yet we are assuming a speciﬁc trend and treating it as a
ﬁxed input to the CCMPP model. This obvious weakness is introduced for simplicity
and tractability, but improvements can be made by furthering our understanding of HIV
incidence and how the distribution of duration times change as the epidemic matures.
Some steps have been made in this direction by Hallett et al. (2008), who classify the
maturation of epidemics into an early stage, a mature and stable stage, and a mature
and declining stage, and condition their estimates of HIV incidence on this dimension.
More work needs to be done along these lines, with the aim of quantifying the magnitude
of differences in the level of incidence between these stages and the duration of each
stage. Continued tracking of age-speciﬁc trends in HIV prevalence (and accounting for
changes due to the relative contributions of incidence and mortality) is a useful tool for
moving forward on this front (Ghys et al. 2006; Stover et al. 2006; Hallett et al. 2008).
Also, explicitly modeling and estimating the heterogeneity of sexual risk behavior, across
age and over time, will help to improve models for population projections in the context
of HIV/AIDS (Gregson et al. 2007; Stover et al. 2006). While it is plausible that the
age pattern of infection remains stable over time and the overall level changes as the
epidemic matures, it is just as reasonable to expect changes in the age pattern of HIV
incidence due to age-speciﬁc behavioral responses to the risk of infection (Stover et al.
2006; ˙ Zaba et al. 2008). Incorporating behavioral data into the speciﬁcation of the trend
in HIV incidence is a very promising way of improving the CCMPP and other models for
population projection.20
Our ﬁnal point is a methodological one which is motivated by the fact that our re-
sults raise some questions concerning the reliability of the maximum likelihood approach
to estimate the CCMPP parameters. We ﬁnd that several conﬁdence intervals for the
CCMPP parameters include negative values, which is troubling since all of the parameters
are bounded below by zero. Furthermore, there is some evidence that the ML estimates
understate the uncertainty around the parameter estimates. Recall that the predictive in-
tervals for adult prevalence at the KwaZulu-Natal site were too narrow for resident men
and women as well as non-resident men, although this may be related to other sources of
20 Accounting for changes in the infectivity of an individual as a function of the duration of infection, as sug-
gested by Leclerc and Garenne (2007), could also enhance the CCMPP.
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uncertainty not captured by the model (e.g. uncertainty around the trend in HIV incidence
based on the gamma trend).
An alternative approach to estimation is the use of Bayesian methods. Poole and
Raftery (2000) developed the Bayesian melding technique speciﬁcally for use with deter-
ministic models like CCMPP, see also Alkema, Raftery, and Clark (2007). A Bayesian
framework is particularly appealing given the potential need for model comparison, such
as the full and reduced models ﬁt to the South African data. Recall that for the KwaZulu-
Natal model the projections for adult prevalence were generally too low for non-residents
and too high for residents. Given that prevalence is higher among women, it may be
inappropriate to model the epidemic’s level for men and women simultaneously, since
non-resident men and resident women have similar levels of prevalence. This suggests
another model with level parameters for each combination of sex and resident status, per-
haps with additional variation related to the full and reduced speciﬁcations shown in Table
9. In a situation like this it would be invaluable to have an estimation approach that ob-
jectively compares or even combines model ﬁts, and Bayesian approaches exist for both,
see Raftery (1995). Future modeling efforts of HIV/AIDS epidemics should consider
these tools for estimation, projection, and quantifying the uncertainty around the events
of interest.
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